Anti-Aging Breakthrough: Monthly Treatment Extends Mouse Lifespans by 25%

Novel Therapy Promises to Delay Aging and Enhance Healthspan

Groundbreaking Research Unveils a Path to Extended Lifespans and Enhanced Vitality

A groundbreaking study published in the journal Cell Metabolism has revealed a promising new anti-aging therapy that has extended the lifespans of mice by 25%. Conducted by a team of researchers at the UConn School of Medicine, the study has sparked excitement in the medical community and holds potential implications for human aging.

The treatment, which involves a monthly injection, targets the protein interleukin-11 (IL-11), a molecule known to play a role in inflammation and aging. Researchers found that mice lacking the IL-11 gene lived significantly longer than their counterparts. Similarly, mice treated with an antibody that neutralized IL-11 also exhibited extended lifespans.